A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to determine the effectiveness of using a combination of two
different drugs in preventing the transmission of HCV from a HCV positive donor to a HCV
negative solid organ recipient.